Rodolphe Clerval
Company: COAVE THERAPEUTICS
Job title: Chief Executive Officer
Seminars:
Panel Discussion: Discovering Novel Technology for CNS Disorders 5:00 pm
What are the newer procedures for capsid screening platforms for tissue and cell tropism? Which vectors are showing clinical progress? Are there novel vectors showing CNS tropism and selectivity in NHPs? What are the respective challenges for different vector types?Read more
day: Day One
Discussing AAV-ligand Conjugates for Improved Efficacy & Distribution in CNS 4:00 pm
CNS delivery of gene therapy products remains challenging, in particular for achieving deep brain distribution of genetic materials Chemical modification of AAV by new conjugation chemistry enables a rapid generation of rationally designed capsids Generation of several conjugated AAV (coAAV) with improved in vivo transduction and biodistribution propertiesRead more
day: Day One